Item 5.02. Entry Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
(d) Director Election
On December 6, 2021, the Company filed a Current Report on Form 8-K (the
"Report") disclosing that the Board of Directors ("Board") of Curis, Inc. (the
"Company") elected John A. Hohneker, M.D., to serve as a class II director until
the Company's 2022 Annual Meeting of Stockholders and thereafter until his
successor is duly elected and qualified. At the time of filing the Report, the
Board had not made any determinations regarding Dr. Hohneker's committee
assignments. On January 3, 2022, the Board appointed Dr. Hohneker to serve on
the Compensation Committee and the Clinical Program Committee, effective
immediately, in each case until his successor is duly appointed and qualified or
until his earlier resignation or removal. The Company hereby amends the Report
to include the foregoing information on Dr. Hohneker's committee assignments in
Item 5.02. Other than providing this additional information in Item 5.02, no
other disclosure in the Report is amended by this Form 8-K/A.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses